Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...

While Prasad’s views may not align with many of the FDA’s traditional policies, they do fit into a broader MAHA agenda of ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...